Omega-3 long-chain fatty acids strongly induce angiopoietin-like 4 in humans 1,2

Journal of Lipid Research

Volumn 54, Issue 3, 2013, Pages 615-621

  Brands, Myrte ^a   Sauerwein, Hans P ^a   Ackermans, Mariette T ^a   Kersten, Sander ^b   Serlie, Mireille J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Docosahexaenoic acid; Fi sh oil; Insulin sensitivity

Indexed keywords

ANGIOPOIETIN LIKE 4; CLINOLEIC; FISH OIL; INTRALIPID; LONG CHAIN TRIACYLGLYCEROL; OLIVE OIL; OMEGA 3 FATTY ACID; REGULATOR PROTEIN; SODIUM CHLORIDE; SOYBEAN OIL; UNCLASSIFIED DRUG;

ADULT; ANGIOPOIETIN LIKE 4 BLOOD LEVEL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATOMA CELL; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN SENSITIVITY; LEAN BODY WEIGHT; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; RAT;

ANGIOPOIETINS; ANIMALS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; HUMANS; MALE; RATS;

EID: 84874046997     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M030049     Document Type: Article

References (27)

1. Kersten, S. 2005. Regulation of lipid metabolism via angiopoietinlike proteins. Biochem. Soc. Trans. 33 : 1059-1062.
2. Yoshida, K., T. Shimizugawa, M. Ono, and H. Furukawa. 2002. Angiopoietin-like protein4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43 : 1770-1772.
3. Xu, A., M. C. Lam, K. W. Chan, Y. Wang, J. Zhang, R. L. Hoo, J. Y. Xu, B. Chen, W. S. Chow, A. W. Tso, et al. 2005. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc. Natl. Acad. Sci. USA. 102 : 6086-6091.
4. Mandard, S., F. Zandbergen, E. van Straten, W. Wahli, F. Kuipers, M. Muller, and S. Kersten. 2006. The fasting-induced adipose factor/angiopoietin- like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281 : 934-944.
5. Kersten, S., L. Lichtenstein, E. Steenbergen, K. Mudde, H. F. Hendriks, M. K. Hesselink, P. Schrauwen, and M. Muller. 2009. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler. Thromb. Vasc. Biol. 29 : 969-974.
6. Staiger, H., C. Haas, J. Machann, R. Werner, M. Weisser, F. Schick, F. Machicao, N. Stefan, A. Fritsche, and H. U. Haring. 2009. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes. 58 : 579-589.
7. Georgiadi, A., L. Lichtenstein, T. Degenhardt, M. V. Boekschoten, M. van Bilsen, B. Desvergne, M. Muller, and S. Kersten. 2010. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ. Res. 106 : 1712-1721.
8. Kersten, S., S. Mandard, N. S. Tan, P. Escher, D. Metzger, P. Chambon, F. J. Gonzalez, B. Desvergne, and W. Wahli. 2000. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275 : 28488-28493.
9. Yoon, J. C., T. W. Chickering, E. D. Rosen, B. Dussault, Y. Qin, A. Soukas, J. M. Friedman, W. E. Holmes, and B. M. Spiegelman. 2000. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 20 : 5343-5349.
10. Expert Committee on the Diagnosis and Classifi cation of Diabetes Mellitus. 2003. Report of the expert committee on the diagnosis and classifi cation of diabetes mellitus. Diabetes Care. 26 (Suppl. 1): S5-S20.
11. Brands, M., J. Hoeks, H. P. Sauerwein, A. T. Ackermans, M. Ouwens, N. M. Lammers, M. N. van der Plas, P. Schrauwen, A. K. Groen, and M. J. Serlie. 2011. Short-term increase of plasma free fatty acidsdoes not interfere with intrinsic mitochondrial function in healthy young men. Metabolism. 60 : 1398-1405.
12. Ackermans, M. T., A. F. Ruiter, and E. Endert. 1998. Determination of glycerol concentrations and glycerol isotopic enrichments in human plasma by gas chromatography/mass spectrometry. Anal. Biochem. 258 : 80-86.
13. Ackermans, M. T., A. M. Pereira Arias, P. H. Bisschop, E. Endert, H. P. Sauerwein, and J. A. Romijn. 2001. The quantifi cation of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13) C]glycerol. J. Clin. Endocrinol. Metab. 86 : 2220-2226.
14. Finegood, D. T., R. N. Bergman, and M. Vranic. 1987. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes. 36 : 914-924.
15. Steele, R. 1959. Infl uences of glucose loading and of injected insulin on hepatic glucose output. Ann. N. Y. Acad. Sci. 82 : 420-430.
16. Mattijssen, F., and S. Kersten. 2012. Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochim. Biophys. Acta. 1821: 782-789.
17. van Raalte, D. H., M. Brands, M. J. Serlie, K. Mudde, R. Stienstra, H. P. Sauerwein, S. Kersten, and M. Diamant. 2012. Angiopoietinlike protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans. Exp. Clin. Endocrinol. Diabetes. 120 : 598-603.
18. Lichtenstein, L., and S. Kersten. 2010. Modulation of plasma TG lipolysis by angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta. 1801 : 415-420.
19. Sanderson, L. M., T. Degenhardt, A. Koppen, E. Kalkhoven, B. Desvergne, M. Muller, and S. Kersten. 2009. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol. Cell. Biol. 29 : 6257-6267.
20. Krey, G., O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, and W. Wahli. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identifi ed as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 : 779-791.
21. Mandard, S., F. Zandbergen, N. S. Tan, P. Escher, D. Patsouris, W. Koenig, R. Kleemann, A. Bakker, F. Veenman, W. Wahli, et al. 2004. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofi-brate treatment. J. Biol. Chem. 279 : 34411-34420.
22. Köster, A., Y. B. Chao, M. Mosior, A. Ford, P. A. Gonzalez-DeWhitt, J. E. Hale, D. Li, Y. Qiu, C. C. Fraser, D. D. Yang, et al. 2005. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology. 146 : 4943-4950.
23. Wang, Y., P. Puthanveetil, F. Wang, M. S. Kim, A. Abrahani, and B. Rodrigues. 2011. Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly. Diabetes. 60 : 2041-2050.
24. Staiger, H., F. Machicao, R. Werner, A. Guirguis, M. Weisser, N. Stefan, A. Fritsche, and H. U. Haring. 2008. Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. Metabolism. 57 : 637-643.
25. Romeo, S., L. A. Pennacchio, Y. Fu, E. Boerwinkle, A. Tybjaerg-Hansen, H. H. Hobbs, and J. C. Cohen. 2007. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39 : 513-516.
26. Ruge, T., V. Sukonina, O. Kroupa, E. Makoveichuk, M. Lundgren, M. K. Svensson, G. Olivecrona, and J. W. Eriksson. 2012. Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus. Metabolism. 61 : 652-660.
27. Belfort, R., L. Mandarino, S. Kashyap, K. Wirfel, T. Pratipanawatr, R. Berria, R. A. DeFronzo, and K. Cusi. 2005. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 54 : 1640-1648.